| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Departments of Neurology,
2 Ophthalmology,
3 Pathology,
4 Radiology, and
5 Chemistry, Washington University School of Medicine, St. Louis, Missouri, and
6 Center for Developmental Biology and Kent Waldrep Foundation Center for Basic Research on Nerve Growth and Regeneration, University of Texas Southwestern Medical Center, Dallas, Texas
Whereas biallelic neurofibromatosis 1 (NF1) inactivation is observed in NF1-associated gliomas, astrocyte-restricted Nf1 conditional knockout mice do not develop gliomas. These observations suggest that NF1 glioma formation requires additional cellular or genetic conditions. To determine the effect of an Nf1 heterozygous brain environment on NF1 glioma formation, we generated Nf1+/- mice lacking Nf1 expression in astrocytes. In contrast to astrocyte-restricted Nf1 conditional knockout mice, Nf1+/- mice lacking Nf1 in astrocytes develop optic nerve gliomas. This mouse model demonstrates that Nf1+/- cells contribute to the pathogenesis of gliomas in NF1 and provides a tool for the preclinical evaluation of potential therapeutic interventions for these tumors.
This article has been cited by other articles:
|
|
 |
|
  N. de la Iglesia, G. Konopka, K.-L. Lim, C. L. Nutt, J. F. Bromberg, D. A. Frank, P. S. Mischel, D. N. Louis, and A. Bonni Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness J. Neurosci., June 4, 2008; 28(23): 5870 - 5878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hegedus, D. Banerjee, T.-H. Yeh, S. Rothermich, A. Perry, J. B. Rubin, J. R. Garbow, and D. H. Gutmann Preclinical Cancer Therapy in a Mouse Model of Neurofibromatosis-1 Optic Glioma Cancer Res., March 1, 2008; 68(5): 1520 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. de la Iglesia, G. Konopka, S. V. Puram, J. A. Chan, R. M. Bachoo, M. J. You, D. E. Levy, R. A. DePinho, and A. Bonni Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway Genes & Dev., February 15, 2008; 22(4): 449 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Warrington, B. M. Woerner, G. C. Daginakatte, B. Dasgupta, A. Perry, D. H. Gutmann, and J. B. Rubin Spatiotemporal Differences in CXCL12 Expression and Cyclic AMP Underlie the Unique Pattern of Optic Glioma Growth in Neurofibromatosis Type 1 Cancer Res., September 15, 2007; 67(18): 8588 - 8595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Sandsmark, H. Zhang, B. Hegedus, C. L. Pelletier, J. D. Weber, and D. H. Gutmann Nucleophosmin Mediates Mammalian Target of Rapamycin-Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes Cancer Res., May 15, 2007; 67(10): 4790 - 4799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Daginakatte and D. H. Gutmann Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth Hum. Mol. Genet., May 1, 2007; 16(9): 1098 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, S. A. Estwick, S. Chen, M. Yu, W. Ming, T. D. Nebesio, Y. Li, J. Yuan, R. Kapur, D. Ingram, et al. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells Hum. Mol. Genet., October 1, 2006; 15(19): 2837 - 2845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Theos and B. R. Korf Pathophysiology of neurofibromatosis type 1. Ann Intern Med, June 6, 2006; 144(11): 842 - 849. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhu, T. Harada, L. Liu, M. E. Lush, F. Guignard, C. Harada, D. K. Burns, M. L. Bajenaru, D. H. Gutmann, and L. F. Parada Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation Development, December 15, 2005; 132(24): 5577 - 5588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dasgupta, Y. Yi, B. Hegedus, J. D. Weber, and D. H. Gutmann Cerebrospinal Fluid Proteomic Analysis Reveals Dysregulation of Methionine Aminopeptidase-2 Expression in Human and Mouse Neurofibromatosis 1-Associated Glioma Cancer Res., November 1, 2005; 65(21): 9843 - 9850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dasgupta and D. H. Gutmann Neurofibromin Regulates Neural Stem Cell Proliferation, Survival, and Astroglial Differentiation In Vitro and In Vivo J. Neurosci., June 8, 2005; 25(23): 5584 - 5594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dasgupta, Y. Yi, D. Y. Chen, J. D. Weber, and D. H. Gutmann Proteomic Analysis Reveals Hyperactivation of the Mammalian Target of Rapamycin Pathway in Neurofibromatosis 1-Associated Human and Mouse Brain Tumors Cancer Res., April 1, 2005; 65(7): 2755 - 2760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dasgupta, W. Li, A. Perry, and D. H. Gutmann Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes Cancer Res., January 1, 2005; 65(1): 236 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Scheidenhelm and D. H. Gutmann Mouse Models of Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 726 - 733. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
